BioTech Medics logo

BioTech Medics(OTC) BMCS

Market Cap$41.10KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2004)-100%
5 Year-100%
1 Year-98%
1 Month-80%
$0.00
+0.00%
+0.00Today
BioTech Medics last closing stock price
MetricPriceDate
Last closeUSD 0.002026-09-15
BioTech Medics stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-09-08
1 month-80%USD 0.002026-07-29
3 month-80%USD 0.002026-06-05
Year to date-97.5%USD 0.012025-12-31
1 year-97.65%USD 0.012025-09-12
3 year-98.67%USD 0.022023-09-15
5 year-99.67%USD 0.062021-09-16
Since inception-100%USD 21.002004-12-07

BioTech Medics Financials at a Glance

Market Cap

$41.10KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

$6.25K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

20.05 (High)

Price

$0.00

Volume

6,465

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.01

Estimated Earnings Date

N/A

BMCS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About BioTech Medics

BioTech Medics, Inc. is a holding company focused on the medical field, managing therapeutic laser clinics that treat various pain conditions. The company also develops and markets nutraceutical products aimed at enhancing health and wellness.

Products and Services
  • Therapeutic laser clinics for pain management
  • SHBAN, an antiseptic sanitizing solution
  • BioBody Balance and BioBody Energy Spray nutritional supplements
Growth Outlook
  • Expansion of laser clinics across multiple states
  • Increasing demand for non-invasive pain management solutions
  • Growing market for nutritional supplements in retail channels
Financial Highlights
  • Recent quarterly net income of $52,171, indicating potential profitability
  • Trailing twelve months (TTM) revenue of $0, reflecting early-stage growth
  • Operating expenses decreased significantly in the latest quarter
BioTech Medics, Inc. operates in the healthcare sector, specifically within the drug manufacturing industry, focusing on specialty and generic products. The company has established a presence in Texas, California, New Mexico, and Florida, providing therapeutic laser treatments that address pain from various conditions. Additionally, BioTech Medics offers a range of nutraceutical products, including an antiseptic solution and vitamin supplements, which are gaining traction in the retail market. The growth outlook for BioTech Medics appears promising, with plans for expansion in therapeutic services and a rising demand for non-invasive treatment options. The nutritional supplement market is also expanding, providing additional revenue opportunities. Recent financial data shows a positive net income in the latest quarter, suggesting a potential shift towards profitability. Although the TTM revenue remains at $0, the reduction in operating expenses indicates improved financial management. Overall, BioTech Medics, Inc. presents an intriguing opportunity for investors interested in the healthcare and wellness sectors.
AI Generated • Sep 10, 2026

Industry

Healthcare Providers and Services

CEO

Anthony Keith Miller, MBA

Headquarters

Southlake, TX 76092-0114, US

BMCS Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-0.00%

Return on Capital

-0.00%

Return on Assets

-0.00%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$41.10KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

205.36M

Volume

6.46K

Avg. Volume

1.56K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$6.25K

EBITDA

$12.19K

Operating Cash Flow

$8.00

Capital Expenditure

-$7.00

Free Cash Flow

-$5.00

Cash & ST Invst.

-$302.00

Total Debt

$2.00K

BioTech Medics Performance Analysis

BioTech Medics annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 0N/A
20222022-12-31USD 0N/A
20232023-12-31USD 0N/A
20242024-12-31USD 0N/A
BioTech Medics sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-30N/A
Q32024-09-30N/A
Q42024-12-31N/A
Q12025-03-31N/A
BioTech Medics annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD -0.00N/A
20222022-12-31USD -0.00-62.5%
20232023-12-31USD 0.00N/A
20242024-12-31USD 0.00N/A
BioTech Medics sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-30100.0%
Q32024-09-30N/A
Q42024-12-31250.0%
Q12025-03-31-100.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$41.10KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

0

N/A

Net Income

-$3.36K

+73.2%

EBITDA

-$3.36K

+73.2%

Quarterly Fundamentals

Name
Q1 2025YOY CHG

Total Cash

-$302.00

-102.8%

Total Debt

$2.00K

+0.0%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$2.00K

+0.0%

Return on Assets

-0.00%

N/A

Return on Invested Capital

-0.00%

N/A

Free Cash Flow

$52.11K

+333.7%

Operating Cash Flow

$52.11K

+333.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
EDXCEndexx Corporation
$0.00+0.00%
SRUTFSproutly Canada Inc.
$0.00+0.00%
MJNAMedical Marijuana, Inc.
$0.00+0.00%
HBRMHerborium Group, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$103.97+1.61%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$50.11-1.94%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$40.61-0.03%
NOKNokia
$10.14+3.05%

Questions About BMCS

What is the current price of BioTech Medics?

BioTech Medics is trading at $0.00 per share.

What is the 52-week range for BioTech Medics?

Over the past 52 weeks, BioTech Medics has traded between $0.00 and $0.01.

How much debt does BioTech Medics have?

As of the most recent reporting period, BioTech Medics reported total debt of $2.00K.

How much cash does BioTech Medics have on hand?

BioTech Medics reported -$302.00 in cash and cash equivalents in its most recent financial results.

What is BioTech Medics’s dividend yield?

BioTech Medics does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.